By targeting tumor-cell CD47 through a decoy receptor (SiRPαFc), reverting the “do-not-eat-me” signal to bystander macrophages, a significant reduction of tumor load was observed in various hematologic malignancies, i.e., CTCL [76]. Here, CD47 is linked to neoplasm.